GS-2121 / Gilead - LARVOL DELTA

Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=154 | Recruiting | Sponsor: Gilead Sciences | Not yet recruiting ➔ Recruiting

Enrollment open • Oncology • Solid Tumor

Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=154 | Not yet recruiting | Sponsor: Gilead Sciences

Metastases • Monotherapy • New P1 trial • Oncology • Solid Tumor